Actinogen Medical Limited has released a press release.
Underwriting of unlisted options completed
Earlier from Actinogen Medical
- ACW unlisted options fully underwritten
- ACW FY2026 results and outlook
- June 2026 Quarterly activity report & Appendix 4C
- Xanamem depression trial published in British J Psychiatry